Inactive Instrument

Insiders Cardiome Pharma Corp Nasdaq

Equities

Mark Corrigan Departs as CEO from Correvio Pharma Corp	27/20/27	CI
Correvio Pharma Corp. Announces Management Changes	27/20/27	CI
Correvio Pharma Corp. Approves Appointment of W. James O'Shea as Director	19/19/19	CI
Correvio Pharma Corp. Announces Management Changes	13/19/13	CI
Correvio Pharma Corp Announces Executive Changes	02/19/02	CI
Cardiome Pharma Corp. Announces Management Changes	16/17/16	CI
Cardiome Pharma Corp. Announces Management Appointments	08/16/08	CI
Cardiome Pharma Corp. Announces Addition of Robert James Meyer to Board of Directors	08/15/08	CI
Cardiome Pharma Corp. Announces Executive Appointments	24/15/24	CI
Cardiome Pharma Corp. Appoints David Dean as Vice President, Business Development and Investor Relations	03/15/03	CI
Cardiome Pharma Announces Nomination of W. James O'Shea to Board of Directors	10/14/10	CI
Cardiome Pharma Appoints Jürgen Polifka, Ph.D., as General Manager, Sales and Marketing Europe	02/13/02	CI
Cardiome Pharma Corp. Adds Dr. Steen Juul-Möller as Medical Director, Europe	28/13/28	CI
Cardiome Pharma Corp. Announces Changes in Senior Management Team	27/13/27	CI
Cardiome Pharma Corp. Appoints Jennifer Archibald as Chief Financial Officer	21/12/21	CI
Cardiome Pharma Corp. Announces Management Change	03/12/03	CI

No results for this search